Controversy Surrounding KT&G's Funding for Overseas Business Trips

Business by 2FIRSTS.ai
Jan.26.2024
Controversy Surrounding KT&G's Funding for Overseas Business Trips
KT&G, a South Korean tobacco company, faces controversy over using company funds to sponsor overseas trips for non-executive directors.

According to a report by the South Korean newspaper, The Korea Economic Daily, on the 24th, KT&G, a South Korean tobacco company, has been revealed to annually use company funds to support non-executive directors' business trips abroad, sparking controversy over the company's fund usage.

 

According to sources familiar with the matter, the former president of KT&G, Baek Pok-in, has decided not to seek reelection and a new president will be elected at the shareholders' meeting in March. Among the board members, six are non-executive directors, some of whom have previously embarked on luxurious overseas business trips.

 

KT&G has announced that since 2012, some of its directors have been taking annual trips abroad. These trips are typically made to countries where KT&G has a presence and serve the purpose of conducting "overseas training" or "overseas business inspections." Some directors have even taken the opportunity to visit tourist attractions with their family members.

 

KT&G provides business class round-trip tickets and hotel accommodations to non-executive directors, along with additional cash for expenses such as meals and transportation. When questioned, company staff explained that these overseas business trips are aimed at gaining insights into global operations. Directors visit local markets and production facilities, meet with overseas experts, and study potential new business opportunities. KT&G emphasizes that these trips are in line with company regulations.

 

According to sources, KT&G incurs an average overseas business travel expense of approximately 6.8 million Korean won per non-executive director, excluding airfare. However, controversy surrounds the involvement of non-executive directors in activities such as cruise trips and hot air balloon experiences during these business trips. KT&G's staff has clarified that "these incidents occurred in 2012 and 2014 and have no relation to the current non-executive directors."

 

Baek Pok-in's decision not to seek re-election and the controversy surrounding his involvement as a non-executive director in overseas business trips could potentially impact the company's future governance structure and financial transparency.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | ELFBAR Launches New Open-System Device in UK with Three Pod Options and 2800mAh Battery
Product | ELFBAR Launches New Open-System Device in UK with Three Pod Options and 2800mAh Battery
ELFBAR has launched its new open-system device ELFX MEGA, compatible with 2 mL, 5 mL and 10 mL pods and equipped with a 2800mAh battery that delivers significantly longer runtime than its predecessor. The device has passed MHRA notification in the UK and is now available online in the UK at a retail price of around £18.99.
Nov.25 by 2FIRSTS.ai
Kenya Court of Appeal Halts BBC Defamation Case Linked to BAT Bribery Documentary
Kenya Court of Appeal Halts BBC Defamation Case Linked to BAT Bribery Documentary
Kenya’s Court of Appeal has paused the defamation proceedings filed by National Assembly Speaker Moses Wetang’ula against the BBC. The case centers on a 2015 BBC documentary, Panorama: The Secret Bribes of Big Tobacco, which alleged that Wetang’ula received unlawful benefits from British American Tobacco (BAT) during his tenure as a senator.
Dec.02 by 2FIRSTS.ai
Russian police seize counterfeit e-cigarettes and tobacco products in Novosibirsk,products valued at about 1.3 million rubles
Russian police seize counterfeit e-cigarettes and tobacco products in Novosibirsk,products valued at about 1.3 million rubles
Russian police in Novosibirsk bust counterfeit e-cigarette and tobacco products, seizing items worth 1.3 million rubles. Consideration for criminal charges.
Oct.13 by 2FIRSTS.ai
Philip Morris International Fails to Invalidate British American Tobacco Unit’s Vape Patent
Philip Morris International Fails to Invalidate British American Tobacco Unit’s Vape Patent
The European Patent Office’s Board of Appeal upheld British American Tobacco’s Nicoventures Trading Ltd. vape patent, rejecting Philip Morris International’s objections. The board ruled that the patent’s use of predefined heater activation parameters not based on user puffs was novel and valid.
Nov.10
Product | FLONQ Parent Company Launches New Vaping Brand ROQY: Two Hybrid-Nicotine Devices Debut in Russia
Product | FLONQ Parent Company Launches New Vaping Brand ROQY: Two Hybrid-Nicotine Devices Debut in Russia
Alfabet Labs, the parent company of FLONQ, has recently launched its new vaping brand ROQY in Russia, debuting two products: ROQY L and ROQY M. Both devices use a hybrid nicotine formulation combining nicotine salts and freebase nicotine and are each available in 19 flavors. The two products are now on sale via the official ROQY website as well as multiple online and offline retailers across Russia.
Nov.19 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai